Physiopathology and treatment of fatigue in multiple sclerosis

作者: G. Comi , L. Leocani , P. Rossi , B. Colombo

DOI: 10.1007/S004150170222

关键词:

摘要: Fatigue is a common symptom of patients with multiple sclerosis (MS). It reported by about one-third patients, and for many fatigue the most disabling symptom. may be associated motor disturbances and/or mood disorders, which makes it very difficult to determine whether an aspect these features or result per se disease. Although peripheral mechanisms have some role in pathogenesis fatigue, MS there are clear indications that more important played “central” abnormalities. Neurophysiological studies shown does not depend on involvement pyramidal tracts implicate impairment volitional drive descending pathways as physiopathological mechanism. Metabolic abnormalities frontal cortex basal ganglia revealed positronemission tomography correlations between magnetic resonance imaging lesion burden support this hypothesis. Some recent also suggest pro-inflammatory cytokines contribute sense tiredness. No specific treatments available. Management strategies include medications, exercise, behavioural therapy; cases combined approach appropritate.

参考文章(30)
B. Bigland-Ritchie, D. A. Jones, G. P. Hosking, R. H. T. Edwards, Central and peripheral fatigue in sustained maximum voluntary contractions of human quadriceps muscle Clinical Science. ,vol. 54, pp. 609- 614 ,(1978) , 10.1042/CS0540609
Freal Je, Kraft Gh, Coryell Jk, Symptomatic fatigue in multiple sclerosis Archives of Physical Medicine and Rehabilitation. ,vol. 65, pp. 135- 138 ,(1984)
T.J. Murray, Amantadine therapy for fatigue in multiple sclerosis. Canadian Journal of Neurological Sciences. ,vol. 12, pp. 251- 254 ,(1985) , 10.1017/S0317167100047107
R. H. T. Edwards, Human Muscle Function and Fatigue Novartis Foundation Symposia. ,vol. 82, pp. 1- 18 ,(2008) , 10.1002/9780470715420.CH1
Bruno Colombo, Filippo Martinelli Boneschi, Paolo Rossi, Marco Rovaris, Luca Maderna, Massimo Filippi, Giancarlo Comi, MRI and motor evoked potential findings in nondisabled multiple sclerosis patients with and without symptoms of fatique Journal of Neurology. ,vol. 247, pp. 506- 509 ,(2000) , 10.1007/S004150070148
R. Djaldetti, I. Ziv, A. Achiron, E. Melamed, Fatigue in multiple sclerosis compared with chronic fatigue syndrome A quantitative assessment Neurology. ,vol. 46, pp. 632- 635 ,(1996) , 10.1212/WNL.46.3.632
Charles L. Rice, Timothy L. Vollmer, Brenda Bigland-Ritchie, Neuromuscular responses of patients with multiple sclerosis Muscle & Nerve. ,vol. 15, pp. 1123- 1132 ,(1992) , 10.1002/MUS.880151011
Joaquim P. Brasil-Neto, Leonardo G. Cohen, Mark Hallett, Central fatigue as revealed by postexercise decrement of motor evoked potentials. Muscle & Nerve. ,vol. 17, pp. 713- 719 ,(1994) , 10.1002/MUS.880170702
Jane A. Kent-Braun, Khema R. Sharma, Michael W. Weiner, Robert G. Miller, Effects of exercise on muscle activation and metabolism in multiple sclerosis Muscle & Nerve. ,vol. 17, pp. 1162- 1169 ,(1994) , 10.1002/MUS.880171006
L. B. Krupp, P. K. Coyle, C. Doscher, A. Miller, A. H. Cross, L. Jandorf, J. Halper, B. Johnson, L. Morgante, R. Grimson, Fatigue therapy in multiple sclerosis Results of a double‐blind, randomized, parallel trial of amantadine, pemoline, and placebo Neurology. ,vol. 45, pp. 1956- 1961 ,(1995) , 10.1212/WNL.45.11.1956